SIBEPRENLIMAB

SIBEPRENLIMAB was reported 689 times

SIBEPRENLIMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FLANK DISCOMFORT 1 0.1667
1 HUMAN PAPILLOMAVIRUS REACTIVATION 1 0.0769
2 ABDOMINAL WALL PAIN 1 0.0588
3 HANTAVIRAL INFECTION 1 0.0476
4 VACCINATION SITE PRURITUS 1 0.0196
5 DRUG-DEVICE INTERACTION 2 0.0180
6 CSF SHUNT OPERATION 1 0.0139
7 DEVICE TEMPERATURE ISSUE 1 0.0133
8 IMPLANTABLE CARDIAC MONITOR INSERTION 1 0.0088
9 VENTRICULO-PERITONEAL SHUNT 1 0.0088
10 EXTERNAL EAR PAIN 1 0.0085
11 CYTOTOXIC LESIONS OF CORPUS CALLOSUM 1 0.0068
12 CREATININE URINE DECREASED 1 0.0063
13 EAR INFECTION VIRAL 1 0.0063
14 CORONAVIRUS PNEUMONIA 1 0.0060
15 INJECTION SITE COLDNESS 5 0.0059
16 ORAL BACTERIAL INFECTION 1 0.0055
17 SUSPECTED DRUG-INDUCED LIVER INJURY 1 0.0050
18 SLEEVE GASTRECTOMY 1 0.0041
19 NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL INCREASED 1 0.0037
20 EYE INFECTION VIRAL 1 0.0031
21 BLOOD TRIGLYCERIDES DECREASED 1 0.0030
22 COLOUR BLINDNESS ACQUIRED 1 0.0028
23 DENTAL DISCOMFORT 2 0.0024
24 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 1 0.0023
25 TREATMENT DELAYED 4 0.0023
26 BLOOD ALBUMIN INCREASED 2 0.0022
27 RESPIRATORY SYMPTOM 6 0.0021
28 PROTEIN URINE PRESENT 10 0.0020
29 TRI-IODOTHYRONINE DECREASED 1 0.0019
30 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
31 ENDOSCOPY 1 0.0017
32 INJECTION SITE DISCOMFORT 17 0.0016
33 NASAL PRURITUS 2 0.0016
34 NASAL CRUSTING 1 0.0015
35 BLOOD IMMUNOGLOBULIN A DECREASED 1 0.0015
36 GINGIVAL DISCOMFORT 1 0.0015
37 IMMUNOGLOBULINS DECREASED 2 0.0015
38 H1N1 INFLUENZA 2 0.0014
39 INJECTION SITE HYPOAESTHESIA 2 0.0014
40 ALANINE AMINOTRANSFERASE DECREASED 1 0.0014
41 TENDON DISCOMFORT 1 0.0013
42 MUSCLE DISCOMFORT 1 0.0013
43 SUPERINFECTION BACTERIAL 1 0.0013
44 BLOOD IMMUNOGLOBULIN G DECREASED 3 0.0012
45 HAND-FOOT-AND-MOUTH DISEASE 1 0.0012
46 OOPHORECTOMY 1 0.0011
47 SALIVA ALTERED 1 0.0011
48 INJECTION SITE DRYNESS 1 0.0011
49 PROTEIN URINE 1 0.0011
50 URINE ABNORMALITY 5 0.0011
51 SUSPECTED PRODUCT QUALITY ISSUE 2 0.0011
52 DISTURBANCE IN SEXUAL AROUSAL 1 0.0011
53 LUPUS NEPHRITIS 2 0.0011
54 INJECTION SITE SCAB 1 0.0010
55 UPPER RESPIRATORY TRACT CONGESTION 3 0.0010
56 BLOOD IMMUNOGLOBULIN M DECREASED 1 0.0010
57 INJECTION SITE SWELLING 75 0.0010
58 SINUSITIS BACTERIAL 1 0.0009
59 GASTROINTESTINAL ULCER 2 0.0009
60 CARBON DIOXIDE DECREASED 1 0.0009
61 CHEMICAL BURN 1 0.0009
62 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 2 0.0008
63 FEAR OF INJECTION 6 0.0008
64 URINE FLOW DECREASED 2 0.0008
65 RENAL TRANSPLANT 3 0.0008
66 BLEEDING TIME PROLONGED 1 0.0008
67 PHARYNGEAL INFLAMMATION 1 0.0008
68 ALLERGY TO CHEMICALS 1 0.0008
69 LIP DISCOLOURATION 1 0.0008
70 GLUCOSE URINE PRESENT 1 0.0008
71 NOCTURNAL DYSPNOEA 1 0.0008
72 PROTEIN TOTAL ABNORMAL 1 0.0008
73 PRODUCT PACKAGING DIFFICULT TO OPEN 2 0.0008
74 INJECTION SITE DISCHARGE 4 0.0007
75 VULVOVAGINAL CANDIDIASIS 1 0.0007
76 SKIN WRINKLING 2 0.0007
77 INJECTION SITE PRURITUS 47 0.0007
78 NOROVIRUS INFECTION 1 0.0007
79 BLOOD CREATINE INCREASED 3 0.0007
80 CUSHINGOID 2 0.0006
81 INJECTION SITE RASH 19 0.0006
82 PRODUCT PREPARATION ISSUE 4 0.0006
83 TONSILLAR HYPERTROPHY 1 0.0006
84 FOOD AVERSION 1 0.0006
85 SKIN WOUND 1 0.0006
86 ENTERITIS INFECTIOUS 1 0.0006
87 GLOMERULAR FILTRATION RATE DECREASED 7 0.0006
88 TERMINAL INSOMNIA 1 0.0006
89 INTRA-ABDOMINAL FLUID COLLECTION 1 0.0006
90 NASAL OBSTRUCTION 1 0.0005
91 PROTEIN TOTAL DECREASED 2 0.0005
92 INJECTION SITE URTICARIA 13 0.0005
93 PRODUCT STORAGE ISSUE 2 0.0005
94 INJECTION SITE VESICLES 3 0.0005
95 ESCHERICHIA INFECTION 4 0.0005
96 INJECTION SITE DISCOLOURATION 6 0.0005
97 UPPER RESPIRATORY TRACT INFECTION 22 0.0005
98 EYE CONTUSION 1 0.0005
99 OLIGOMENORRHOEA 1 0.0005
100 IDIOPATHIC INTRACRANIAL HYPERTENSION 1 0.0004
101 NECK SURGERY 1 0.0004
102 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
103 SINUS PAIN 1 0.0004
104 TRANSPLANT 1 0.0004
105 LYMPHADENITIS 1 0.0004
106 INJECTION SITE ERYTHEMA 51 0.0004
107 SUFFOCATION FEELING 1 0.0004
108 INJECTION SITE INFLAMMATION 2 0.0004
109 INJECTION SITE BRUISING 32 0.0004
110 KLEBSIELLA INFECTION 2 0.0004
111 INJECTION SITE IRRITATION 5 0.0004
112 INJECTION SITE INDURATION 5 0.0004
113 RENAL PAIN 4 0.0004
114 PROTEIN TOTAL INCREASED 1 0.0004
115 BREAST SWELLING 1 0.0004
116 PROTEINURIA 7 0.0004
117 RHINALGIA 1 0.0004
118 PERIORBITAL SWELLING 2 0.0004
119 DIALYSIS 5 0.0004
120 INJECTION SITE SCAR 1 0.0004
121 PRODUCT ADMINISTRATION ERROR 7 0.0003
122 IMMUNOSUPPRESSION 3 0.0003
123 ENERGY INCREASED 2 0.0003
124 ACNE CYSTIC 1 0.0003
125 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
126 DERMATITIS ACNEIFORM 2 0.0003
127 INJECTION SITE PAIN 100 0.0003
128 FLANK PAIN 3 0.0003
129 INJECTION SITE HYPERSENSITIVITY 1 0.0003
130 FOREIGN BODY IN THROAT 1 0.0003
131 BLOOD URINE PRESENT 6 0.0003
132 UNDERDOSE 23 0.0003
133 BLOOD POTASSIUM INCREASED 5 0.0003
134 SKIN INJURY 1 0.0003
135 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
136 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 1 0.0003
137 SEASONAL ALLERGY 4 0.0003
138 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
139 CUTANEOUS VASCULITIS 1 0.0003
140 ARTHROPOD BITE 2 0.0003
141 OESOPHAGEAL DISORDER 1 0.0003
142 RHINORRHOEA 16 0.0002
143 GALLBLADDER OPERATION 1 0.0002
144 INJECTION SITE WARMTH 5 0.0002
145 GENERALISED OEDEMA 3 0.0002
146 SPINAL STENOSIS 1 0.0002
147 LABORATORY TEST ABNORMAL 7 0.0002
148 INTESTINAL STENOSIS 1 0.0002
149 MUSCLE FATIGUE 1 0.0002
150 POOR PERIPHERAL CIRCULATION 1 0.0002
151 NASOPHARYNGITIS 43 0.0002
152 EXPOSURE VIA SKIN CONTACT 6 0.0002
153 HORDEOLUM 1 0.0002
154 GROIN PAIN 2 0.0002
155 DEVICE DIFFICULT TO USE 15 0.0002
156 EAR INFECTION 6 0.0002
157 ILLNESS 23 0.0002
158 CHROMATURIA 5 0.0002
159 PAPILLOEDEMA 1 0.0002
160 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
161 RENAL FUNCTION TEST ABNORMAL 1 0.0002
162 NEPHROPATHY 2 0.0002
163 VAGINAL INFECTION 1 0.0002
164 COLITIS MICROSCOPIC 1 0.0002
165 DEVICE LEAKAGE 9 0.0002
166 NEEDLE ISSUE 6 0.0002
167 NASAL CONGESTION 12 0.0002
168 HYPERVOLAEMIA 1 0.0002
169 ABDOMINAL TENDERNESS 1 0.0002
170 FLUID INTAKE REDUCED 1 0.0002
171 PRODUCT COLOUR ISSUE 1 0.0002
172 RESPIRATORY TRACT INFECTION 5 0.0002
173 PETECHIAE 2 0.0002
174 JOINT STIFFNESS 5 0.0002
175 FOOD POISONING 1 0.0002
176 PHARYNGITIS STREPTOCOCCAL 2 0.0002
177 BLOOD CREATININE INCREASED 12 0.0002
178 OROPHARYNGEAL PAIN 17 0.0002
179 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
180 INJECTION SITE INJURY 1 0.0002
181 STREPTOCOCCAL INFECTION 1 0.0002
182 INTRACRANIAL PRESSURE INCREASED 1 0.0002
183 DERMATITIS CONTACT 2 0.0002
184 MOUTH SWELLING 1 0.0002
185 BLOOD URIC ACID INCREASED 1 0.0002
186 DEVICE USE ERROR 6 0.0002
187 SYRINGE ISSUE 3 0.0002
188 URINE ODOUR ABNORMAL 1 0.0002
189 COVID-19 PNEUMONIA 2 0.0002
190 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
191 CATARACT OPERATION 1 0.0002
192 THIRST 3 0.0002
193 DEVICE ISSUE 15 0.0002
194 GOUT 3 0.0002
195 RENAL IMPAIRMENT 14 0.0002
196 GANGRENE 1 0.0002
197 OLIGURIA 1 0.0002
198 BLEPHAROSPASM 1 0.0002
199 BRONCHIECTASIS 1 0.0001
200 SINUS CONGESTION 2 0.0001
201 BODY TEMPERATURE INCREASED 3 0.0001
202 SKIN REACTION 2 0.0001
203 PAPULE 1 0.0001
204 VISUAL FIELD DEFECT 1 0.0001
205 SENSITIVE SKIN 1 0.0001
206 SNEEZING 3 0.0001
207 KETOACIDOSIS 1 0.0001
208 GENERAL SYMPTOM 1 0.0001
209 TENDON PAIN 1 0.0001
210 GASTROINTESTINAL INFLAMMATION 1 0.0001
211 BRAIN FOG 2 0.0001
212 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
213 NASAL DISCOMFORT 1 0.0001
214 GINGIVAL PAIN 1 0.0001
215 BLOOD PRESSURE FLUCTUATION 3 0.0001
216 POST PROCEDURAL INFECTION 1 0.0001
217 SWELLING FACE 8 0.0001
218 ASPHYXIA 1 0.0001
219 POLYURIA 1 0.0001
220 INFLUENZA LIKE ILLNESS 10 0.0001
221 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
222 PHOTOSENSITIVITY REACTION 2 0.0001
223 MENSTRUAL DISORDER 1 0.0001
224 EYE PRURITUS 4 0.0001
225 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
226 HYSTERECTOMY 1 0.0001
227 SKIN SWELLING 1 0.0001
228 INCORRECT DOSE ADMINISTERED BY DEVICE 3 0.0001
229 COUGH 32 0.0001
230 PURPURA 1 0.0001
231 GASTROINTESTINAL INFECTION 1 0.0001
232 TOOTHACHE 2 0.0001
233 PNEUMONIA BACTERIAL 1 0.0001
234 NERVE COMPRESSION 1 0.0001
235 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 5 0.0001
236 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
237 SPUTUM DISCOLOURED 1 0.0001
238 POST PROCEDURAL COMPLICATION 2 0.0001
239 PERIPHERAL SWELLING 16 0.0001
240 DIZZINESS POSTURAL 1 0.0001
241 AUTOIMMUNE DISORDER 1 0.0001
242 VITAMIN D DEFICIENCY 1 0.0001
243 LIGAMENT SPRAIN 1 0.0001
244 SINUS DISORDER 2 0.0001
245 BLADDER DISORDER 1 0.0001
246 BLOOD PRESSURE ABNORMAL 2 0.0001
247 HYPOTONIA 1 0.0001
248 OVARIAN CYST 1 0.0001
249 DEVICE BREAKAGE 4 0.0001
250 DRY THROAT 1 0.0001
251 SLUGGISHNESS 1 0.0001
252 INITIAL INSOMNIA 1 0.0001
253 DEPRESSED MOOD 5 0.0001
254 LIVER FUNCTION TEST INCREASED 2 0.0001
255 MENSTRUATION DELAYED 1 0.0001
256 BLOOD PRESSURE DECREASED 6 0.0001
257 SINUSITIS 9 0.0001
258 FATIGUE 68 0.0001
259 ALOPECIA 17 0.0001
260 PERICARDIAL EFFUSION 2 0.0001
261 HYPERSENSITIVITY 16 0.0001
262 ELECTROLYTE IMBALANCE 1 0.0001
263 SWELLING 8 0.0001
264 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 17 0.0001
265 NOCTURIA 1 0.0001
266 PRESYNCOPE 2 0.0001
267 SPINAL OPERATION 1 0.0001
268 INJECTION SITE MASS 3 0.0001
269 DYSGEUSIA 6 0.0001
270 PHARYNGITIS 1 0.0001
271 HAIR COLOUR CHANGES 1 0.0001
272 ABDOMINAL PAIN LOWER 2 0.0001
273 FLUID RETENTION 4 0.0001
274 HAEMATOMA 2 0.0001
275 IMMUNE SYSTEM DISORDER 1 0.0001
276 TOOTH INFECTION 1 0.0001
277 PULMONARY CONGESTION 1 0.0001
278 FREQUENT BOWEL MOVEMENTS 2 0.0001
279 OEDEMA 4 0.0001
280 FEELING COLD 2 0.0001
281 HUNGER 1 0.0001
282 INFLUENZA 8 0.0001
283 APHONIA 1 0.0001
284 SKIN EXFOLIATION 6 0.0001
285 IMPAIRED QUALITY OF LIFE 1 0.0001
286 BACK PAIN 16 0.0001
287 APATHY 1 0.0001
288 PRODUCT STORAGE ERROR 6 0.0001
289 GASTROENTERITIS 1 0.0001
290 OESOPHAGEAL CARCINOMA 2 0.0001
291 PULMONARY MASS 1 0.0001
292 RESPIRATORY DISORDER 2 0.0001
293 VERTIGO 4 0.0001
294 NEPHROLITHIASIS 3 0.0001
295 RESPIRATORY TRACT CONGESTION 1 0.0001
296 PRODUCTIVE COUGH 3 0.0001
297 SCIATICA 1 0.0001
298 INJECTION SITE HAEMORRHAGE 5 0.0001
299 CONTUSION 6 0.0001
300 SENSORY DISTURBANCE 1 0.0001
301 DYSPEPSIA 6 0.0001
302 PYREXIA 21 0.0001
303 VIRAL INFECTION 2 0.0001
304 BLOOD UREA INCREASED 1 0.0001
305 CANDIDA INFECTION 1 0.0001
306 URINARY TRACT INFECTION 10 0.0001
307 DIZZINESS 29 0.0001
308 INFLAMMATION 3 0.0001
309 MUSCULOSKELETAL DISCOMFORT 1 0.0001
310 PRODUCT DOSE OMISSION ISSUE 17 0.0001
311 ORTHOSTATIC HYPOTENSION 1 0.0001
312 NERVOUSNESS 3 0.0001
313 RASH MACULAR 2 0.0001
314 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
315 HEAD DISCOMFORT 1 0.0001
316 ADVERSE DRUG REACTION 5 0.0001
317 GASTROENTERITIS VIRAL 1 0.0001
318 RASH PRURITIC 3 0.0001
319 HYPOTENSION 11 0.0001
320 END STAGE RENAL DISEASE 1 0.0001
321 PRURITUS 21 0.0001
322 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
323 CONJUNCTIVITIS 1 0.0001
324 NECK PAIN 3 0.0001
325 ABDOMINAL DISCOMFORT 9 0.0001
326 MIDDLE INSOMNIA 1 0.0001
327 ERYTHEMA 11 0.0001
328 HYPOAESTHESIA 8 0.0001
329 BLISTER 3 0.0001
330 MUSCULAR WEAKNESS 6 0.0001
331 SLEEP APNOEA SYNDROME 1 0.0001
332 INCREASED APPETITE 1 0.0001
333 BLOOD PRESSURE INCREASED 8 0.0001
334 LETHARGY 3 0.0001
335 PULMONARY FIBROSIS 1 0.0001
336 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
337 ORAL HERPES 1 0.0001
338 CHILLS 6 0.0001
339 DISORIENTATION 2 0.0001
340 IRRITABILITY 3 0.0000
341 JOINT SWELLING 6 0.0000
342 PRODUCT PHYSICAL ISSUE 1 0.0000
343 TASTE DISORDER 1 0.0000
344 INJURY ASSOCIATED WITH DEVICE 1 0.0000
345 BLINDNESS 2 0.0000
346 MUSCLE SPASMS 9 0.0000
347 POLLAKIURIA 2 0.0000
348 ABDOMINAL DISTENSION 5 0.0000
349 DERMATITIS 1 0.0000
350 RETCHING 1 0.0000
351 POOR QUALITY SLEEP 1 0.0000
352 PRODUCT PRESCRIBING ISSUE 1 0.0000
353 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
354 RASH PAPULAR 1 0.0000
355 THROAT IRRITATION 2 0.0000
356 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
357 PAIN IN EXTREMITY 13 0.0000
358 SKIN IRRITATION 2 0.0000
359 INJECTION SITE REACTION 3 0.0000
360 NEURALGIA 1 0.0000
361 ARTHRALGIA 17 0.0000
362 NAUSEA 32 0.0000
363 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
364 GASTRIC CANCER 1 0.0000
365 RASH 17 0.0000
366 MALAISE 17 0.0000
367 DIPLOPIA 1 0.0000
368 HEADACHE 24 0.0000
369 DEAFNESS 1 0.0000
370 ECZEMA 2 0.0000
371 GASTRITIS 1 0.0000
372 DEHYDRATION 5 0.0000
373 MENSTRUATION IRREGULAR 1 0.0000
374 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
375 SKIN LESION 1 0.0000
376 HAEMATOCHEZIA 2 0.0000
377 DIVERTICULITIS 1 0.0000
378 PROCEDURAL PAIN 1 0.0000
379 DIARRHOEA 23 0.0000
380 RED BLOOD CELL COUNT DECREASED 1 0.0000
381 HYPERSOMNIA 1 0.0000
382 INFECTION 5 0.0000
383 DYSSTASIA 1 0.0000
384 ABDOMINAL PAIN UPPER 7 0.0000
385 WHEEZING 2 0.0000
386 GASTROINTESTINAL DISORDER 3 0.0000
387 BLOOD POTASSIUM DECREASED 1 0.0000
388 LACRIMATION INCREASED 1 0.0000
389 HYPERTENSION 7 0.0000
390 CONSTIPATION 7 0.0000
391 SWOLLEN TONGUE 1 0.0000
392 HEAD INJURY 1 0.0000
393 PULMONARY EMBOLISM 3 0.0000
394 NIGHT SWEATS 1 0.0000
395 EXPIRED PRODUCT ADMINISTERED 1 0.0000
396 INSOMNIA 8 0.0000
397 FUNGAL INFECTION 1 0.0000
398 SOMNOLENCE 6 0.0000
399 TYPE 2 DIABETES MELLITUS 1 0.0000
400 MYALGIA 5 0.0000
401 ASTHENIA 11 0.0000
402 WEIGHT DECREASED 8 0.0000
403 COVID-19 5 0.0000
404 HEART RATE DECREASED 1 0.0000
405 LYMPHADENOPATHY 1 0.0000
406 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
407 VOMITING 13 0.0000
408 RESTLESSNESS 1 0.0000
409 DYSURIA 1 0.0000
410 HEPATIC FUNCTION ABNORMAL 1 0.0000
411 DYSPNOEA EXERTIONAL 1 0.0000
412 HOT FLUSH 2 0.0000
413 PALPITATIONS 3 0.0000
414 DRUG DOSE OMISSION BY DEVICE 2 0.0000
415 ARTHRITIS 2 0.0000
416 FEELING ABNORMAL 6 0.0000
417 HYPOACUSIS 1 0.0000
418 DEVICE DISLOCATION 1 0.0000
419 MUSCULOSKELETAL STIFFNESS 2 0.0000
420 PAIN 14 0.0000
421 ANGIOEDEMA 1 0.0000
422 DRY SKIN 3 0.0000
423 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
424 PULMONARY OEDEMA 1 0.0000
425 VISION BLURRED 3 0.0000
426 TINNITUS 1 0.0000
427 ADVERSE EVENT 2 0.0000
428 PNEUMONIA 7 0.0000
429 CHEST PAIN 4 0.0000
430 DECREASED APPETITE 5 0.0000
431 RENAL DISORDER 1 0.0000
432 BLOOD CHOLESTEROL INCREASED 1 0.0000
433 ARRHYTHMIA 1 0.0000
434 MIGRAINE 2 0.0000
435 BLOOD GLUCOSE DECREASED 1 0.0000
436 HYPOGLYCAEMIA 1 0.0000
437 DRY EYE 1 0.0000
438 CELLULITIS 1 0.0000
439 ACUTE KIDNEY INJURY 3 0.0000
440 CHEST DISCOMFORT 2 0.0000
441 PARAESTHESIA 3 0.0000
442 DISTURBANCE IN ATTENTION 1 0.0000
443 URTICARIA 3 0.0000
444 WEIGHT INCREASED 4 0.0000
445 HYPONATRAEMIA 1 0.0000
446 EYE PAIN 1 0.0000
447 FLATULENCE 1 0.0000
448 DEPRESSION 4 0.0000
449 HERPES ZOSTER 1 0.0000
450 EYE IRRITATION 1 0.0000
451 DYSPHONIA 1 0.0000
452 BONE PAIN 1 0.0000
453 DISEASE PROGRESSION 2 0.0000
454 ILL-DEFINED DISORDER 1 0.0000
455 PLEURAL EFFUSION 1 0.0000
456 DISCOMFORT 1 0.0000
457 VISUAL IMPAIRMENT 2 0.0000
458 BLOOD GLUCOSE INCREASED 3 0.0000
459 DEEP VEIN THROMBOSIS 1 0.0000
460 RENAL FAILURE 2 0.0000
461 HEPATIC ENZYME INCREASED 1 0.0000
462 INJURY 1 0.0000
463 SKIN BURNING SENSATION 1 0.0000
464 OFF LABEL USE 12 0.0000
465 BRONCHITIS 1 0.0000
466 EPISTAXIS 1 0.0000
467 ACNE 1 0.0000
468 INCORRECT DOSE ADMINISTERED 3 0.0000
469 ABDOMINAL PAIN 3 0.0000
470 CARDIAC FAILURE 1 0.0000
471 CARDIAC FAILURE CONGESTIVE 1 0.0000
472 THROMBOSIS 1 0.0000
473 DRY MOUTH 1 0.0000
474 TREMOR 2 0.0000
475 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
476 ANXIETY 3 0.0000
477 NEUROPATHY PERIPHERAL 1 0.0000
478 ANAEMIA 2 0.0000
479 GAIT DISTURBANCE 2 0.0000
480 ATRIAL FIBRILLATION 1 0.0000
481 HEART RATE INCREASED 1 0.0000
482 SYNCOPE 1 0.0000
483 HAEMOGLOBIN DECREASED 1 0.0000
484 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
485 HAEMORRHAGE 1 0.0000
486 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
487 SEPSIS 1 0.0000
488 DYSPNOEA 5 0.0000
489 RHEUMATOID ARTHRITIS 1 0.0000
490 OEDEMA PERIPHERAL 1 0.0000
491 LOSS OF CONSCIOUSNESS 1 0.0000
492 HYPERHIDROSIS 1 0.0000
493 DRUG INEFFECTIVE 10 0.0000
494 MEMORY IMPAIRMENT 1 0.0000
495 HOSPITALISATION 1 0.0000
496 CONFUSIONAL STATE 1 0.0000
497 CEREBROVASCULAR ACCIDENT 1 0.0000
498 DEATH 3 0.0000
499 CONDITION AGGRAVATED 1 0.0000
500 FALL 1 0.0000